News release 2022 Covis Pharma Announces Positive Topline Results from the AVANT Phase 3 Clinical Trial Showing Significant Improvement in Patients with Moderate to Severe Stable COPD October 25, 2022 Covis Pharma Reports on FDA Advisory Committee Hearing for Makena® October 19, 2022 Covis Pharma Group Announces Executive Leadership Appointment in Canada July 14, 2022 Covis Pharma Provides Update on FDA Public Hearing for Makena® June 14, 2022 Covis Pharma Group Announces Two Executive Management Team Appointments January 31, 2022 Covis Completes Acquisition of Global Respiratory Portfolio of Two Medicines from AstraZeneca January 5, 2022 News release Contact Us 2023 2022 2021 2020 2018 2017 2015 2013
Covis Pharma Announces Positive Topline Results from the AVANT Phase 3 Clinical Trial Showing Significant Improvement in Patients with Moderate to Severe Stable COPD October 25, 2022
Covis Completes Acquisition of Global Respiratory Portfolio of Two Medicines from AstraZeneca January 5, 2022
